Tumor-derived extracellular vesicles carrying PS bind to CD300a on DCs, and suppress TLR3-mediated IFN-β production, leading to enhanced in vitro accumulation of tumor-infiltrating Tregs [60,90]. Here, CD300A is linked to neoplasm.